Forum · Medicine · Story discussion
Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV Melanoma
New England Journal of Medicine, Ahead of Print.
9 days ago — NEJM · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…